FTREFortrea Holdings Inc.
Services-Medical Laboratories
- Revenue
- $2.7B
- 1.0% YoY
- Operating margin
- -32.0%
- 434% YoY
- EBITDA
- −$795M
- 959% YoY
- Market cap
- $2.1B
- Employees
- 14,300
- $190K revenue each
- Net debt / EBITDA
- —
- $811M net debt
- AI in 10-K
- 6.7
- mentions per 10K words
Takeover score 2 of 13
Fixable underperformance 1 of 7
- TSR below peersYes3 of 3 years3+ of last 5 years
- High CEO pay despite TSRNo—Median CEO pay ≥ $15M while TSR trails
- Earnings not backed by cashNo—Cash flow under 80% of net income
- Dilutive SBCNo3% of revenueOver 10% of revenue
- Payouts exceed cash flowNo0% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyNo35% of assetsOver 40% of assets
- Shareholder dissentNo92% lowest supportAny vote under 80% support
Buyer economics 1 of 4
- Low revenue per employeeNo$190K · 36th pctBottom quartile of its SIC industry
- Quiet on AINo6.7 per 10K words · 87th pctBottom quartile of AI mentions in 10-Ks
- Net cashNo—More cash than debt, positive EBITDA
- Buyout-sizedYes$2.1B market capMarket cap $500M–$5B
Catalysts 0 of 2
- Active 13DNo0 filingsActive-intent 13D in 18 months
- Net insider sellingNo−$5M netNet sales over $10M in 12 months
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $3.1B | $2.8B | $2.8B | $2.7B | $2.7B | 1.0% |
| Operating income | $114M | $187M | $32M | −$162M | −$873M | 439% |
| Net income | $98M | $186M | −$25M | −$329M | −$989M | 201% |
| Operating cash flow | $170M | $83M | $168M | $263M | $114M | 57% |
| Capex | $27M | $54M | $40M | $26M | $25M | 1.2% |
| Stock-based comp | $28M | $25M | $43M | $58M | $74M | 27% |
Deal filings
None.
13D filers
| Filed | Filer | Form | Stake | Intent |
|---|---|---|---|---|
| May 12, 2025 | Starboard Value LP | SCHEDULE 13D/A | 3.0% | Passive |
| Feb 24, 2025 | Starboard Value LP | SCHEDULE 13D/A | 16.3% | Active |
| Jan 31, 2025 | Starboard Value LP | SCHEDULE 13D/A | 12.9% | Passive |
| Feb 26, 2024 | Starboard Value LP | SC 13D/A | 6.9% | Passive |
| Oct 17, 2023 | Starboard Value LP | SC 13D | 8.7% | Passive |
Insider trading
- Open-market buys, 12 mo
- $0 · 0
- Open-market sells, 12 mo
- $5M · 24
- Net
- −$5M
Pay vs performance
| Year | CEO total comp | Comp actually paid | TSR (indexed) | Peer TSR |
|---|---|---|---|---|
| FY2025 | — | — | 51 | 121 |
| FY2024 | — | — | 55 | 107 |
| FY2023 | — | — | 103 | 104 |